scispace - formally typeset
Open AccessJournal ArticleDOI

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.

TLDR
A novel SARS-CoV-2 variant, 20E (EU1) that emerged in Spain in early summer, and subsequently spread across Europe is reported in this article.
Abstract
Following its emergence in late 2019, the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1,2 has been tracked via phylogenetic analysis of viral genome sequences in unprecedented detail3–5. While the virus spread globally in early 2020 before borders closed, intercontinental travel has since been greatly reduced. However, within Europe travel resumed in the summer of 2020. Here we report on a novel SARS-CoV-2 variant, 20E (EU1), that emerged in Spain in early summer, and subsequently spread across Europe. We find no evidence of increased transmissibility, but instead demonstrate how rising incidence in Spain, resumption of travel, and lack of effective screening and containment may explain the variant’s success. Despite travel restrictions, we estimate 20E (EU1) was introduced hundreds of times to European countries by summertime travelers, likely undermining local efforts to keep SARS-CoV-2 cases low. Our results demonstrate how a variant can rapidly become dominant even in absence of a substantial transmission advantage in favorable epidemiological settings. Genomic surveillance is critical to understanding how travel can impact SARS-CoV-2 transmission, and thus for informing future containment strategies as travel resumes.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The biological and clinical significance of emerging SARS-CoV-2 variants.

TL;DR: The emergence of SARS-CoV-2 variants with novel spike protein mutations that are influencing the epidemiological and clinical aspects of the COVID-19 pandemic has been witnessed as mentioned in this paper.
Journal ArticleDOI

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2.

TL;DR: In this paper, the authors used a cell surface-binding assay, a kinetics study, a single-molecule technique, and a computational method to investigate the interaction between these RBD (mutations) and ACE2.
Journal ArticleDOI

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.

TL;DR: Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as discussed by the authors.
Journal ArticleDOI

Ongoing global and regional adaptive evolution of SARS-CoV-2.

TL;DR: In this paper, the authors analyzed more than 300,000 high-quality genome sequences of SARS-CoV-2 variants available as of January 2021, and found that the ongoing evolution of CoV2 during the COVID-19 pandemic is characterized primarily by purifying selection, but a small set of sites appear to evolve under positive selection.
Journal ArticleDOI

The Lancet Commission on lessons for the future from the COVID-19 pandemic

TL;DR: The COVID-19 Commission report as mentioned in this paper provides a conceptual framework for understanding pandemics and proposes guideposts for strengthening the multilateral system to address global emergencies and to achieve sustainable development.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform

TL;DR: A simplified scoring system is proposed that performs well for reducing CPU time and increasing the accuracy of alignments even for sequences having large insertions or extensions as well as distantly related sequences of similar length.
Journal ArticleDOI

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

TL;DR: It is demonstrating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination, and it is shown that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of Sars- coV- 2 S and SARS S bind with similar affinities to human ACE2, correlating with the efficient spread of SATS among humans.
Related Papers (5)